Rchr
J-GLOBAL ID:200901020377176676   Update date: Feb. 01, 2024

Aso Teijiro

アソウ テイジロウ | Aso Teijiro
Affiliation and department:
Research field  (4): Pathobiochemistry ,  Neuropathology ,  Molecular biology ,  Medical biochemistry
Research keywords  (8): Alzheimer's disease ,  drug discovery ,  protein degradation ,  ubiquitin ligase ,  RNAポリメラーゼII ,  Elongin ,  transcription elongation ,  regulation of gene expression
Research theme for competitive and other funds  (23):
  • 2022 - 2025 Development of an innovative anti-Alzheimer drug that selectively inhibits the ubiquitination of BRI2 and BRI3
  • 2018 - 2021 BRI2/3-ユビキチンリガーゼを標的とする新規認知症治療薬開発のための基盤研究
  • 2015 - 2018 Identification of Elongin A target genes and clarification of the mechanisms governing conversion of the Elongin complex from its elongation factor to its ubiquitin ligase form
  • 2012 - 2015 In vivo role of transcriptional elongation/ubiquitin ligase factor Elongin
  • 2009 - 2011 Role and mechanism of action of mammalian Elongin A in the stress response
Show all
Papers (41):
more...
MISC (13):
more...
Education (1):
  • - 1986 Kochi Medical School
Professional career (1):
  • 博士(医学)
Work history (1):
  • 2001/05 - 現在 Kochi Medical School Department of Functional Genomics Professor
Association Membership(s) (3):
日本生化学会 ,  日本分子生物学会 ,  米国生化学分子生物学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page